康缘药业一季度归母净利润8341万元，同比下降43.7%

财中社2025-04-30

4月29日，康缘药业(600557)公布2025年一季报，公司营业收入为8.78亿元，同比下降35.4%；归母净利润为8341万元，同比下降43.7%；扣非归母净利润为8200万元，同比下降41.3%；经营现金流净额为7694万元，同比下降61.3%；EPS(全面摊薄)为0.1465元。截至一季度末，公司总资产68.85亿元，较上年度末下降0.3%；归母净资产为45.98亿元，较上年度末增长...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2531708252?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-30 15:13","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2531708252","market":"sh","top_or_hot":-1,"title":"康缘药业一季度归母净利润8341万元，同比下降43.7%","media":"财中社","content":"<div>\n<p>4月29日，康缘药业(600557)公布2025年一季报，公司营业收入为8.78亿元，同比下降35.4%；归母净利润为8341万元，同比下降43.7%；扣非归母净利润为8200万元，同比下降41.3%；经营现金流净额为7694万元，同比下降61.3%；EPS(全面摊薄)为0.1465元。截至一季度末，公司总资产68.85亿元，较上年度末下降0.3%；归母净资产为45.98亿元，较上年度末增长...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043015140894e89bd6&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康缘药业一季度归母净利润8341万元，同比下降43.7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康缘药业一季度归母净利润8341万元，同比下降43.7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-30 15:13 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043015140894e89bd6&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月29日，康缘药业(600557)公布2025年一季报，公司营业收入为8.78亿元，同比下降35.4%；归母净利润为8341万元，同比下降43.7%；扣非归母净利润为8200万元，同比下降41.3%；经营现金流净额为7694万元，同比下降61.3%；EPS(全面摊薄)为0.1465元。截至一季度末，公司总资产68.85亿元，较上年度末下降0.3%；归母净资产为45.98亿元，较上年度末增长...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043015140894e89bd6&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600557","symbol_name":"康缘药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043015140894e89bd6&s=b","article_id":"2531708252","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043015140894e89bd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2531708252","pubTimestamp":1745997202,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"4月29日，康缘药业公布2025年一季报，公司营业收入为8.78亿元，同比下降35.4%；归母净利润为8341万元，同比下降43.7%；扣非归母净利润为8200万元，同比下降41.3%；经营现金流净额为7694万元，同比下降61.3%；EPS为0.1465元。截至一季度末，公司总资产68.85亿元，较上年度末下降0.3%；归母净资产为45.98亿元，较上年度末增长1.8%。公司在2025年第一季度报告中提到，已完成对江苏中新医药有限公司100%股权的收购，成为全资子公司，并将其纳入财务报表合并范围。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"600557":"康缘药业"},"translate_title":"Kangyuan Pharmaceutical's net profit attributable to the parent company in the first quarter was 83.41 million yuan, a year-on-year decrease of 43.7%.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600557":1},"content_text":"4月29日，康缘药业(600557)公布2025年一季报，公司营业收入为8.78亿元，同比下降35.4%；归母净利润为8341万元，同比下降43.7%；扣非归母净利润为8200万元，同比下降41.3%；经营现金流净额为7694万元，同比下降61.3%；EPS(全面摊薄)为0.1465元。截至一季度末，公司总资产68.85亿元，较上年度末下降0.3%；归母净资产为45.98亿元，较上年度末增长1.8%。需要注意的是，上年财务数据发生了重述，上文计算基于重述前的数据。公司在2025年第一季度报告中提到，已完成对江苏中新医药有限公司100%股权的收购，成为全资子公司，并将其纳入财务报表合并范围。此次收购旨在增强公司的研发能力和市场竞争力。公司在药品研发方面取得了一系列进展，包括固本消疹颗粒、淫羊藿总黄酮胶囊及连参更年颗粒等药品获得国家药品监督管理局的临床试验批准。这些新药的研发聚焦于代谢性疾病及神经系统疾病，表明公司在创新药物开发上持续发力。在业务运营方面，公司强调将继续推动各项业务的发展，尤其是在药品研发和市场拓展方面。同时，公司控股股东及一致行动人完成了增持计划，显示出对公司未来发展的信心。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2531708252","isCrawlerRequest":true}